Home › Funds › EVENTIDE ASSET MANAGEMENT, LLC › PCVX

EVENTIDE ASSET MANAGEMENT, LLC position in PCVX

VAXCYTE INC · Health Care

EVENTIDE ASSET MANAGEMENT, LLC reported holding 1,380,144 shares of PCVX (VAXCYTE INC) in its Q3 2026 13F filing — a position valued at US$78.5M, representing 1.10% of its reported portfolio and ranking #19 among its reported holdings. EVENTIDE ASSET MANAGEMENT, LLC has disclosed PCVX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)1.38M sh
Reported value held$78.53M
Portfolio Weight1.10%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How EVENTIDE ASSET MANAGEMENT, LLC's PCVX position evolved

EVENTIDE ASSET MANAGEMENT, LLC first disclosed a stake in PCVX in Q3 2023 at 393,000 shares (US$20.0M). The position peaked in Q2 2026 at 1,380,219 shares, worth US$80.2M. Across 13 filings, EVENTIDE ASSET MANAGEMENT, LLC increased the stake 7 time(s), trimmed it 2 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 1,380,144 shares valued at US$78.5M. Notable position changes include a 80% increase in Q2 2025 (shares rose 11% over the following quarter), a 55% trim in Q3 2025 (shares rose 28% over the following quarter), a 142% increase in Q4 2025 (shares rose 26% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 393.00K $20.04M New
Q4 2023 607.21K $38.13M Add
Q1 2024 657.21K $44.89M Add
Q2 2024 739.15K $55.81M Add
Q3 2024 383.45K $43.82M Reduce
Q4 2024 383.45K $31.39M Hold
Q1 2025 470.23K $17.80M Add
Q2 2025 848.14K $27.57M Add
Q3 2025 379.33K $13.66M Reduce
Q4 2025 917.12K $42.31M Add
Q1 2026 1.37M $79.84M Add
Q2 2026 1.38M $80.23M Hold
Q3 2026 1.38M $78.53M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PCVX and 13F data

PCVX (VAXCYTE INC) is a Health Care company. 32 other funds we track also report a position in PCVX — the largest reported positions include Jupiter Topco LLC (US$1.04B), Janus Henderson Group (US$960.2M), T. Rowe Price Investment Management, Inc. (US$709.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PCVX

All PCVX fund holders →

FAQ

How long has EVENTIDE ASSET MANAGEMENT, LLC held PCVX?

EVENTIDE ASSET MANAGEMENT, LLC has disclosed PCVX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is EVENTIDE ASSET MANAGEMENT, LLC's current position in PCVX?

As of Q3 2026, EVENTIDE ASSET MANAGEMENT, LLC holds 1.38M shares of PCVX (VAXCYTE INC), valued at $78.53M, representing 1.10% of its reported portfolio and ranking #19.

Has EVENTIDE ASSET MANAGEMENT, LLC been buying or selling PCVX?

In the latest 13F filing (Q3 2026), EVENTIDE ASSET MANAGEMENT, LLC held unchanged its position in PCVX. The position peaked in Q2 2026 at 1.38M shares.

Which other funds hold PCVX?

Other major institutional holders of PCVX include Jupiter Topco LLC, Janus Henderson Group, T. Rowe Price Investment Management, Inc., among 32 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.